Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update

Lonza Group Ag (OTCMKTS:LZAGY) saw a significant decrease in short interest in September. As of September 15th, there was short interest totaling 27,933 shares, a decrease of 64.1% from the August 31st total of 77,702 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 66,730 shares, the short-interest ratio is currently 0.4 days.

Lonza Group Price Performance

Shares of LZAGY stock traded down $0.49 on Tuesday, reaching $69.97. 17,541 shares of the company’s stock traded hands, compared to its average volume of 71,593. Lonza Group has a 12-month low of $58.53 and a 12-month high of $74.36. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.24. The business’s 50 day moving average price is $69.45 and its two-hundred day moving average price is $66.02.

About Lonza Group

Lonza Group AG is a Switzerland-based contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology and healthcare industries. The company helps customers research, develop and manufacture medicines and other healthcare products, providing services across various stages of the product life cycle.

Its activities include the development and production of biologic medicines, small-molecule pharmaceuticals, active pharmaceutical ingredients, bioconjugates, cell and gene therapies, and other advanced therapeutic modalities.